nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—SLC6A3—attention deficit hyperactivity disorder	0.824	1	CbGaD
Bupropion—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.0133	0.195	CbGeAlD
Bupropion—CHRNA3—Nicotine Activity on Chromaffin Cells—CACNA1C—attention deficit hyperactivity disorder	0.0128	0.118	CbGpPWpGaD
Bupropion—ORM1—saliva—attention deficit hyperactivity disorder	0.00921	0.135	CbGeAlD
Bupropion—CHRNA3—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—attention deficit hyperactivity disorder	0.0077	0.0712	CbGpPWpGaD
Bupropion—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00707	0.104	CbGeAlD
Bupropion—CHRNA3—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0063	0.0582	CbGpPWpGaD
Bupropion—CHRNA3—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.00536	0.0496	CbGpPWpGaD
Bupropion—SLC6A3—Clearance of dopamine—COMT—attention deficit hyperactivity disorder	0.00516	0.0477	CbGpPWpGaD
Bupropion—SLC6A3—Clearance of dopamine—MAOA—attention deficit hyperactivity disorder	0.00513	0.0474	CbGpPWpGaD
Bupropion—CHRNA3—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.005	0.0462	CbGpPWpGaD
Bupropion—CHRNA3—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.00442	0.0409	CbGpPWpGaD
Bupropion—CHRNA3—forebrain—attention deficit hyperactivity disorder	0.00369	0.0543	CbGeAlD
Bupropion—CHRNA3—Nicotine Activity on Dopaminergic Neurons—CHRNA4—attention deficit hyperactivity disorder	0.0032	0.0295	CbGpPWpGaD
Bupropion—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD3—attention deficit hyperactivity disorder	0.00288	0.0266	CbGpPWpGaD
Bupropion—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD4—attention deficit hyperactivity disorder	0.00279	0.0258	CbGpPWpGaD
Bupropion—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD2—attention deficit hyperactivity disorder	0.0026	0.0241	CbGpPWpGaD
Bupropion—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.00236	0.0218	CbGpPWpGaD
Bupropion—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.00234	0.0216	CbGpPWpGaD
Bupropion—SLC6A3—Alpha-synuclein signaling—STUB1—attention deficit hyperactivity disorder	0.00222	0.0205	CbGpPWpGaD
Bupropion—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.00204	0.03	CbGeAlD
Bupropion—CHRNA3—nervous system—attention deficit hyperactivity disorder	0.002	0.0295	CbGeAlD
Bupropion—CHRNA3—central nervous system—attention deficit hyperactivity disorder	0.00193	0.0284	CbGeAlD
Bupropion—CHRNA3—cerebellum—attention deficit hyperactivity disorder	0.00189	0.0277	CbGeAlD
Bupropion—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00165	0.0242	CbGeAlD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00159	0.0147	CbGpPWpGaD
Bupropion—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.00157	0.0145	CbGpPWpGaD
Bupropion—CHRNA3—brain—attention deficit hyperactivity disorder	0.00153	0.0225	CbGeAlD
Bupropion—SLC6A2—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00145	0.0134	CbGpPWpGaD
Bupropion—SLC6A2—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00142	0.0132	CbGpPWpGaD
Bupropion—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.00135	0.0198	CbGeAlD
Bupropion—SLC6A3—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00128	0.0119	CbGpPWpGaD
Bupropion—SLC6A3—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00126	0.0117	CbGpPWpGaD
Bupropion—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00123	0.0181	CbGeAlD
Bupropion—CHRNA3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0012	0.0111	CbGpPWpGaD
Bupropion—ORM1—nervous system—attention deficit hyperactivity disorder	0.00119	0.0175	CbGeAlD
Bupropion—SLC6A2—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.00116	0.0107	CbGpPWpGaD
Bupropion—ORM1—central nervous system—attention deficit hyperactivity disorder	0.00115	0.0169	CbGeAlD
Bupropion—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.00111	0.0163	CbGeAlD
Bupropion—SLC6A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.00109	0.01	CbGpPWpGaD
Bupropion—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.00107	0.0157	CbGeAlD
Bupropion—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.00104	0.0153	CbGeAlD
Bupropion—SLC6A2—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.00103	0.00953	CbGpPWpGaD
Bupropion—CYP2A6—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00103	0.0095	CbGpPWpGaD
Bupropion—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00103	0.0151	CbGeAlD
Bupropion—SLC6A3—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.00103	0.00948	CbGpPWpGaD
Bupropion—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00102	0.0149	CbGeAlD
Bupropion—CYP2A6—brain—attention deficit hyperactivity disorder	0.001	0.0147	CbGeAlD
Bupropion—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000963	0.0142	CbGeAlD
Bupropion—CHRNA3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000917	0.00847	CbGpPWpGaD
Bupropion—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000902	0.0133	CbGeAlD
Bupropion—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000894	0.0131	CbGeAlD
Bupropion—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000861	0.0127	CbGeAlD
Bupropion—SLC6A3—brain—attention deficit hyperactivity disorder	0.000847	0.0125	CbGeAlD
Bupropion—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.000782	0.00723	CbGpPWpGaD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000701	0.00648	CbGpPWpGaD
Bupropion—SLC6A2—brain—attention deficit hyperactivity disorder	0.000683	0.01	CbGeAlD
Bupropion—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000659	0.00968	CbGeAlD
Bupropion—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000634	0.00932	CbGeAlD
Bupropion—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000618	0.00909	CbGeAlD
Bupropion—CHRNA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000613	0.00566	CbGpPWpGaD
Bupropion—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000595	0.00875	CbGeAlD
Bupropion—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000582	0.00855	CbGeAlD
Bupropion—SLC6A3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000578	0.00535	CbGpPWpGaD
Bupropion—CYP2C8—brain—attention deficit hyperactivity disorder	0.000561	0.00825	CbGeAlD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000555	0.00513	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000527	0.00487	CbGpPWpGaD
Bupropion—CYP2B6—brain—attention deficit hyperactivity disorder	0.000503	0.0074	CbGeAlD
Bupropion—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000497	0.00731	CbGeAlD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000491	0.00454	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00049	0.00453	CbGpPWpGaD
Bupropion—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000489	0.0072	CbGeAlD
Bupropion—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000489	0.00452	CbGpPWpGaD
Bupropion—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000479	0.00704	CbGeAlD
Bupropion—CYP2E1—brain—attention deficit hyperactivity disorder	0.000472	0.00695	CbGeAlD
Bupropion—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000471	0.00693	CbGeAlD
Bupropion—CHRNA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000469	0.00434	CbGpPWpGaD
Bupropion—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000461	0.00677	CbGeAlD
Bupropion—SLC6A3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000443	0.0041	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000436	0.00403	CbGpPWpGaD
Bupropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000425	0.00393	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000404	0.00373	CbGpPWpGaD
Bupropion—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000391	0.00361	CbGpPWpGaD
Bupropion—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000377	0.00349	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000375	0.00347	CbGpPWpGaD
Bupropion—CYP2D6—brain—attention deficit hyperactivity disorder	0.000374	0.0055	CbGeAlD
Bupropion—CHRNA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000371	0.00343	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000369	0.00341	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000344	0.00318	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000334	0.00309	CbGpPWpGaD
Bupropion—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000331	0.00306	CbGpPWpGaD
Bupropion—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000316	0.00292	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000306	0.00283	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000304	0.00281	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000296	0.00274	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000284	0.00263	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000282	0.00261	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000282	0.00261	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000269	0.00249	CbGpPWpGaD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000255	0.00236	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000255	0.00235	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000254	0.00235	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00025	0.00231	CbGpPWpGaD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00025	0.00231	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000238	0.0022	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000237	0.00219	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000227	0.0021	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000227	0.00209	CbGpPWpGaD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000216	0.00199	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000195	0.0018	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000193	0.00178	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000181	0.00168	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000179	0.00166	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000178	0.00165	CbGpPWpGaD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000177	0.00164	CbGpPWpGaD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000176	0.00162	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000169	0.00156	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000168	0.00155	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00015	0.00139	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000137	0.00127	CbGpPWpGaD
Bupropion—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000137	0.00127	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000136	0.00126	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000136	0.00126	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000135	0.00125	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000134	0.00124	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000134	0.00123	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000133	0.00123	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000132	0.00122	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000116	0.00107	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000115	0.00107	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000115	0.00106	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000114	0.00105	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	9.89e-05	0.000914	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	9.89e-05	0.000914	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	9.81e-05	0.000907	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	9.48e-05	0.000876	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	9.41e-05	0.00087	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	9.4e-05	0.000869	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	9.35e-05	0.000864	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	9.33e-05	0.000862	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	9.27e-05	0.000857	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	8.03e-05	0.000742	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.97e-05	0.000737	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.92e-05	0.000732	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.91e-05	0.000639	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.2e-05	0.000573	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.15e-05	0.000569	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.11e-05	0.000565	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.58e-05	0.000515	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.46e-05	0.000505	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	4.77e-05	0.000441	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.77e-05	0.000441	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.72e-05	0.000436	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	4.69e-05	0.000434	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.36e-05	0.000403	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.88e-05	0.000358	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	3.85e-05	0.000356	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.85e-05	0.000356	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.84e-05	0.000355	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.81e-05	0.000353	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.79e-05	0.00035	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	3.77e-05	0.000348	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.77e-05	0.000348	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	3.71e-05	0.000343	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.63e-05	0.000336	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.52e-05	0.000325	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.45e-05	0.000319	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.28e-05	0.000304	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.26e-05	0.000301	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	3.26e-05	0.000301	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	3.21e-05	0.000296	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.08e-05	0.000284	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.01e-05	0.000279	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.98e-05	0.000276	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.93e-05	0.000271	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	2.89e-05	0.000267	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	2.87e-05	0.000265	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.87e-05	0.000265	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.68e-05	0.000247	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.68e-05	0.000247	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	2.65e-05	0.000245	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.65e-05	0.000245	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.63e-05	0.000243	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	2.61e-05	0.000241	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.61e-05	0.000241	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.53e-05	0.000234	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.48e-05	0.000229	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.45e-05	0.000226	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.43e-05	0.000224	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	2.33e-05	0.000216	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	2.32e-05	0.000214	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	2.28e-05	0.000211	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.27e-05	0.00021	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	2.27e-05	0.000209	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.27e-05	0.000209	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	2.23e-05	0.000206	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.14e-05	0.000198	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.12e-05	0.000196	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.07e-05	0.000192	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.04e-05	0.000188	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.02e-05	0.000187	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	1.97e-05	0.000183	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	1.96e-05	0.000181	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.9e-05	0.000176	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.81e-05	0.000167	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.75e-05	0.000162	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.75e-05	0.000162	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.72e-05	0.000159	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.72e-05	0.000159	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.62e-05	0.00015	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.61e-05	0.000149	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.61e-05	0.000149	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.6e-05	0.000148	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.6e-05	0.000147	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.55e-05	0.000143	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.4e-05	0.000129	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	1.37e-05	0.000127	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.36e-05	0.000126	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.33e-05	0.000123	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.32e-05	0.000122	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	1.24e-05	0.000115	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	1.06e-05	9.8e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	1.05e-05	9.73e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	1e-05	9.24e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	9.8e-06	9.05e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	8.47e-06	7.83e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	6.95e-06	6.43e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	6.89e-06	6.37e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	5.89e-06	5.44e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	4.54e-06	4.2e-05	CbGpPWpGaD
